Lundbeckfond Invest A/S
Insider CIK 1591046 · CLDN 10% owner · TRVI 10% owner · SCPH 10% owner · IMRA 10% owner · IOBT Director, 10% owner · LXEO 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LXEO Lexeo Therapeutics, Inc. | C Conversion deriv | 2023-11-07 | 2023-11-09 | 13,999,999 | — | $0 | 0 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | C Conversion deriv | 2023-11-07 | 2023-11-09 | 2,615,533 | — | $0 | 0 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | P Buy | 2023-11-07 | 2023-11-09 | 227,272 | $11.00 | $2.50M | 1,835,959 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | C Conversion | 2023-11-07 | 2023-11-09 | 1,321,474 | — | $0 | 1,321,474 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | C Conversion | 2023-11-07 | 2023-11-09 | 287,213 | — | $0 | 1,608,687 | SEC↗ |
| IOBT IO Biotech, Inc. | A Award deriv | 2023-08-09 | 2023-08-11 | 7,901,234 | $0.13 | $1.03M | 7,901,234 | SEC↗ |
| IOBT IO Biotech, Inc. | A Award | 2023-08-09 | 2023-08-11 | 7,901,234 | $1.90 | $15.01M | 13,950,686 | SEC↗ |
| IOBT IO Biotech, Inc. | C Conversion deriv | 2021-11-09 | 2021-11-12 | 150,534 | — | $0 | 0 | SEC↗ |
| IOBT IO Biotech, Inc. | C Conversion deriv | 2021-11-09 | 2021-11-12 | 219,595 | — | $0 | 0 | SEC↗ |
| IOBT IO Biotech, Inc. | P Buy | 2021-11-09 | 2021-11-12 | 2,142,857 | $14.00 | $30.00M | 6,049,452 | SEC↗ |
| IOBT IO Biotech, Inc. | C Conversion | 2021-11-09 | 2021-11-12 | 1,892,434 | — | $0 | 3,906,595 | SEC↗ |
| IOBT IO Biotech, Inc. | C Conversion | 2021-11-09 | 2021-11-12 | 2,014,161 | — | $0 | 2,014,161 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 478,749 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 1,894,444 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 5,470,492 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion | 2020-03-16 | 2020-03-16 | 1,245,222 | — | $0 | 1,245,222 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2020-03-16 | 2020-03-16 | 187,500 | $16.00 | $3.00M | 1,432,722 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 6,849,315 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion | 2019-05-09 | 2019-05-13 | 776,544 | — | $0 | 776,544 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2019-05-09 | 2019-05-13 | 375,000 | $10.00 | $3.75M | 1,151,544 | SEC↗ |
| SCPH scPharmaceuticals Inc. | C Conversion deriv | 2017-11-21 | 2017-11-21 | 11,092,383 | — | $0 | 0 | SEC↗ |
| SCPH scPharmaceuticals Inc. | C Conversion deriv | 2017-11-21 | 2017-11-21 | 7,067,945 | — | $0 | 0 | SEC↗ |
| SCPH scPharmaceuticals Inc. | C Conversion | 2017-11-21 | 2017-11-21 | 984,366 | — | $0 | 2,529,224 | SEC↗ |
| SCPH scPharmaceuticals Inc. | C Conversion | 2017-11-21 | 2017-11-21 | 1,544,858 | — | $0 | 1,544,858 | SEC↗ |
| SCPH scPharmaceuticals Inc. | P Buy | 2017-11-21 | 2017-11-21 | 654,762 | $14.00 | $9.17M | 3,183,986 | SEC↗ |
| CLDN Celladon Corp | C Conversion deriv | 2014-02-04 | 2014-02-06 | 358,049 | — | $0 | 0 | SEC↗ |
| CLDN Celladon Corp | C Conversion deriv | 2014-02-04 | 2014-02-06 | 28,666 | — | $0 | 28,666 | SEC↗ |
| CLDN Celladon Corp | C Conversion deriv | 2014-02-04 | 2014-02-06 | 19,289,531 | — | $0 | 0 | SEC↗ |
| CLDN Celladon Corp | C Conversion deriv | 2014-02-04 | 2014-02-06 | 18,605 | $8.00 | $148.8K | 0 | SEC↗ |
| CLDN Celladon Corp | P Buy | 2014-02-04 | 2014-02-06 | 182,681 | $8.00 | $1.46M | 1,745,683 | SEC↗ |
| CLDN Celladon Corp | C Conversion | 2014-02-04 | 2014-02-06 | 18,605 | $8.00 | $148.8K | 1,563,002 | SEC↗ |
| CLDN Celladon Corp | C Conversion | 2014-02-04 | 2014-02-06 | 1,544,397 | — | $0 | 1,544,397 | SEC↗ |